How We Drive Key Outcomes

Working together to create a rich repository of approximately 15,000 anonymized image scans and clinical data, OSIC will use machine learning to develop algorithms. It will then promote the incorporation of those algorithms into commercial analysis tools.

​Our goal from the beginning has been to make rapid progress in the fight against IPF and other interstitial lung diseases. Thanks to the commitment of our corporate and academic partners we are well on the way.